The burden of chronic kidney disease in Mexico. Data analysis based on the Global Burden of Disease 2021 study
Eduardo R. Argaiz(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Gerardo Gamba(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Linda Morales‐Juárez(Tecnológico de Monterrey), Christian Razo(University of Washington), Rodolfo Rincón-Pedrero(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Quinn Rafferty(Institute for Health Metrics and Evaluation), Liane Ong(Tecnológico de Monterrey)
Cited by 8
Related Papers
Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021
|The Lancet Rheumatology|2023|1.7k
Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
|The Lancet Haematology|2023|541
Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
|The Lancet Global Health|2025|72
The Swiss Brain Health Plan 2023–2033
|Clinical and Translational Neuroscience|2023|39
Estimating global direct health-care spending on neurological and mental health between 2000 and 2019: a modelling study
|The Lancet Public Health|2025|15